Clopidogrel-taking behavior by drug-eluting stent patients: Discontinuers versus continuers

Patient Preference and Adherence

Volumn 2, Issue , 2008, Pages 167-175

  Decker, Carole ^a   Garavalia, Linda ^b   Garavalia, Brian ^a   Spertus, John A ^a  

^a SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

Drug eluting stent post care; Medication discontinuance; Myocardial infarction

Indexed keywords

EID: 77952969775     PISSN: None     EISSN: 1177889X     Source Type: Journal    
DOI: 10.2147/PPA.S3443     Document Type: Article

References (23)

1. Bebbington P.E. 1995. The content and context of compliance. Int Clin Psychopharmacol, 9(Suppl 5):41-50.
2. Becker M.H. 1974. The health belief model and sick role behavior. Health Education Monographs, 2:409-19.
3. Bhatt D. L, Topol EJ. 2004. Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial. Am Heart J, 148:263-8.
4. Conrad P. 1985. The meaning of medications: another look at compliance. Soc Sci Med, 20:29-37.
5. DiMatteo MR, Giordani PJ, Lepper HS, et al. 2002. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care, 40:794-811.
6. Eisenstein E. L, Anstrom KJ, Kong DF, et al. 2007. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA, 297:159-68.
7. George J., Kong DC, Thoman R, et al. 2005. Factors associated with medication nonadherence in patients with COPD. Chest, 128:3198-204.
8. Grines C. L, Bonow RO, Casey DE, Jr., et al. 2007. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation, 115:813-18.
9. Ho P. M, Spertus JA, Masoudi FA, et al. 2006. Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med, 166:1842-7.
10. Hsieh H. F, Shannon SE. 2005. Three approaches to qualitative content analysis. Qual Health Res, 15:1277-88.
11. Iakovou I., Schmidt T, Bonizzoni E, et al. 2005. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA, 293:2126-30.
12. Janz N. K, Becker MH. 1984. The Health Belief Model: a decade later. Health Educ Q, 11:1-47.
13. Kripalani S., LeFevre F, Phillips CO, et al. 2007. Deficits in communication and information transfer between hospital-based and primary care physicians: implications for patient safety and continuity of care. JAMA, 297:831-41.
14. Lewis B. S, Mehta SR, Fox KA, et al. 2005. Benefit of clopidogrel according to timing of percutaneous coronary intervention in patients with acute coronary syndromes: further results from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study. Am Heart J, 150:1177-84.
15. Marshall M.N. 1996. Sampling for qualitative research. Fam Pract, 13:522-5.
16. Morris L. S, Schulz RM. 1992. Patient compliance--an overview. J Clin Pharm Ther, 17:283-95.
17. Rosenstock I.M. 1966. Why people use health services. Milbank Mem Fund Q., 44 (Suppl):94-127.
18. Russell C. L, Conn VS, Jantarakupt P. 2006. Older adult medication compliance: integrated review of randomized controlled trials. Am J Health Behav, 30:636-50.
19. Spertus J. A, Kettelkamp R, Vance C, et al. 2006. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation, 113:2803-9.
20. Stimson G.V. 1974. Obeying doctor's orders: a view from the other side. Soc Sci Med, 8:97-104.
21. Sud A., Kline-Rogers EM, Eagle KA, et al. 2005. Adherence to medications by patients after acute coronary syndromes. Ann Pharmacother, 39:1792-7.
22. Tarn D. M, Heritage J, Paterniti DA, et al. 2006. Physician communication when prescribing new medications. Arch Intern Med, 166:1855-62.
23. Vermeire E., Hearnshaw H, Van Royen P, et al. 2001. Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther, 26:331-42.